We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCI icon
526
Service Corp International
SCI
$11.4B
$1.75M 0.02%
37,565
+13,767
+58% +$594K
TMUS icon
527
T-Mobile US
TMUS
$193B
$1.75M 0.02%
23,679
-16,877
-42% -$1.25M
JKHY icon
528
Jack Henry & Associates
JKHY
$10.7B
$1.74M 0.02%
13
+4
+44% +$553
XYZ
529
Block Inc
XYZ
$45.9B
$1.74M 0.02%
24,055
+1,159
+5% +$81K
LUMN icon
530
Lumen
LUMN
$6.53B
$1.73M 0.02%
147,941
+1,678
+1% +$18.9K
WDC icon
531
Western Digital
WDC
$179B
$1.73M 0.02%
48,403
+9,397
+24% +$322K
HAL icon
532
Halliburton
HAL
$27.9B
$1.73M 0.02%
76,278
-640
-0.8% -$16.6K
CLX icon
533
Clorox
CLX
$11.6B
$1.73M 0.02%
11,320
LGND icon
534
Ligand Pharmaceuticals
LGND
$6.02B
$1.71M 0.02%
24,045
IDXX icon
535
Idexx Laboratories
IDXX
$42.9B
$1.69M 0.02%
6,174
DOC icon
536
Healthpeak Properties
DOC
$15.4B
$1.68M 0.02%
52,872
-7,887
-13% -$245K
CGNX icon
537
Cognex
CGNX
$10.3B
$1.65M 0.02%
34,452
+25,593
+289% +$1.23M
GAP
538
The Gap Inc
GAP
$6.84B
$1.65M 0.02%
92,028
-5,103
-5% -$114K
BBWI icon
539
Bath & Body Works
BBWI
$4.01B
$1.63M 0.02%
77,759
-143,324
-65% -$2.83M
KR icon
540
Kroger
KR
$34.8B
$1.61M 0.02%
74,304
+10,688
+17% +$260K
ENB icon
541
Enbridge
ENB
$124B
$1.6M 0.02%
44,560
-46,730
-51% -$1.7M
IEX icon
542
IDEX
IEX
$16.5B
$1.59M 0.02%
9,299
-2,710
-23% -$426K
BF.B icon
543
Brown-Forman Class B
BF.B
$12B
$1.59M 0.02%
28,819
+1,101
+4% +$58.8K
TCOM icon
544
Trip.com Group
TCOM
$27.5B
$1.59M 0.02%
43,245
LVS icon
545
Las Vegas Sands
LVS
$30.5B
$1.58M 0.02%
26,911
-3,145
-10% -$195K
WHR icon
546
Whirlpool
WHR
$2.42B
$1.58M 0.02%
11,166
+6,603
+145% +$885K
ETN icon
547
Eaton
ETN
$157B
$1.58M 0.02%
19
+5
+36% +$405
IX icon
548
ORIX
IX
$44B
$1.57M 0.02%
105
+80
+320% +$1.15K
SYRS
549
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.56M 0.02%
16,900
-3,500
-17% -$244K
MEOH icon
550
Methanex
MEOH
$4.32B
$1.55M 0.02%
34,315
+700
+2% +$35.1K

Similar funds

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.